TerrAscend FY2025 EPS Forecast Lowered by Seaport Res Ptn

TerrAscend Corp. (OTCMKTS:TSNDF) – Investment analysts at Seaport Res Ptn decreased their FY2025 earnings per share estimates for TerrAscend in a report issued on Monday, November 10th. Seaport Res Ptn analyst S. Randhawa now forecasts that the company will earn ($0.09) per share for the year, down from their previous estimate of ($0.08). The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share.

TerrAscend (OTCMKTS:TSNDF) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). TerrAscend had a negative return on equity of 18.32% and a negative net margin of 42.72%.The company had revenue of $65.10 million for the quarter, compared to analyst estimates of $65.97 million.

Separately, Canaccord Genuity Group raised shares of TerrAscend to a “strong-buy” rating in a report on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, TerrAscend currently has an average rating of “Strong Buy”.

TerrAscend Trading Down 8.6%

Shares of OTCMKTS TSNDF opened at $0.67 on Thursday. TerrAscend has a 1-year low of $0.23 and a 1-year high of $1.25. The company has a 50-day moving average of $0.79 and a two-hundred day moving average of $0.58. The company has a market cap of $205.18 million, a PE ratio of -1.63 and a beta of 1.45. The company has a current ratio of 1.56, a quick ratio of 1.12 and a debt-to-equity ratio of 2.54.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.